Charles River Laboratories | Pasivo Circulante



Current Liabilities Cambio Fecha
Agilent USD 2.01B 143M 2025-04
Align Technology USD 1.99B 47.08M 2025-03
Bio-Rad Laboratories USD 548.9M 42.3M 2025-06
Bruker USD 1.34B 60.3M 2025-03
Cardinal Health USD 36.66B 1.44B 2025-03
Charles River Laboratories USD 1.05B 56.95M 2025-03
Cigna USD 55.74B 2.23B 2025-03
CVS Health USD 94.16B 5.2B 2025-06
Danaher USD 6.79B 147M 2025-06
Dentsply International USD 1.79B 204M 2025-03
Elevance Health 43.83B 1.14B 2025-06
Galapagos EUR 402.95M 34.09M 2025-06
Hologic USD 962.5M 27.2M 2025-06
Humana 16.94B 1.79B 2024-12
Illumina USD 1.44B 107M 2025-03
Incyte USD 1.28B 608.18M 2025-06
IQVIA Holdings USD 7.57B 393M 2025-06
Laboratory Of America USD 2.72B 652.2M 2025-06
Lonza CHF 3.58B 970M 2024-12
McKesson USD 61.6B 3.04B 2025-03
Merck EUR 9.5B 1.79B 2025-03
Mettler Toledo International USD 1.15B 18.5M 2025-03
Novartis USD 31.71B 95M 2025-06
Pfizer USD 36.45B 6.54B 2025-03
Quest Diagnostics USD 2.02B 583M 2025-06
Revvity USD 671.81M 23.63M 2025-06
Thermo Fisher Scientific USD 12.72B 456M 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06
UnitedHealth 113.47B 9.7B 2025-03
Walgreens Boots Alliance USD 25.96B 627M 2025-05
Waters USD 960.97M 171.21M 2025-03
West Pharmaceutical Services USD 604.6M 77.9M 2025-06


Charles River Laboratories Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.